Study of subchronic toxicity of Primalact preparation at intracisternal administration

DOI 10.33861/2071-8020-2020-5-11-13

Summary. Currently, the problem of treatment and prevention of mammary gland diseases in cows is relevant. In this regard, the task of developing new drugs to combat mastitis, with a wide spectrum of antimicrobial activity and minimal side effects, remains relevant. Authors studied subchronic toxicity of Primalact preparation with intracisternal administration to lactating cows. The experiment was performed on 12 clinically healthy cows at the 3rd-4th months of lactation. 3 experimental and 1 control groups were formed. Animals in the experimental groups for 9 days were intracisternally injected in doses of 5, 10 and 20 ml, respectively. Examination data showed the absence of significant changes in the clinical state of the experimental animals and breast tissue in the two experimental groups. In the group with a dose of 20 ml on the 5th day, an increase in the temperature of the udder lobes, their densification, slight pain, the appearance of flakes in the secretion of the udder and a decrease in dairy productivity were detected. In this case it indicated the presence of an irritating effect. The administration of Primalact for 9 days in a dose of 5 ml and 10 ml to lactating cows did not cause any changes in the morphological and biochemical blood parameters. The results of the studies in the fourth experimental group were reflected in the instructions for the application of the drug, which indicated that the frequency of administration of the drug was 3-4 days. Thus, Primalact, when intracisternially administered to lactating cows in doses of 5 and 10 ml for 9 days, does not have subchronic toxicity.

Keywords: large horned cattle, lactating cows, mammary gland, mastitis, Primalact, complex preparation, intracisternal administration of the preparation, subchronic toxicity, blood morphology and biochemistry, blood parameters.

References:

1. Andryukov B.G., Nedashkovskaya E.P. Vstupaya v post-antibiotikovuyu eru: perspektivnye strategii poiska novykh alternativnykh strategiy borby s infektsionnymi zabolevaniyami [Entering post-antibiotic era: promising strategies for finding new alternative strategies for combating infectious diseases]. - DOI: 10.5281/ zenodo.1488026.

2. Artemyeva O.A. Ustoychivost k antibiotikam shtammov Staphylococcus aureus, vydelennykh iz moloka vysokoproduktivnykh korov [Antibiotic resistance of Staphylococcus aureus strains isolated from milk of high yielding cows]. - DOI: 10.15389/agrobiology.2016.6.867rus.

3. Ashenbrenner A.I., Belyaeva N.Yu., Chekunkova Yu.A., Khaperskiy Yu.A. Issledovanie ostroy toksichnosti slozhnogo tkanevogo preparata [Study of acute toxicity of a complex tissue drug]. - Bulletin of ASAU. - Barnaul, 2018 (7 (165). - pp. 122127.

4. Biryukova N.P., Rusakov S.V., Napalkova V.V. Obshchie printsipy doklinicheskoy otsenki bezopasnosti farmakologicheskogo preparata [General principles of preclinical safety assessment of pharmacological drugs for veterinary application]. - Veterinarnyy vrach. - Kazan, 2018 (1). - pp. 3-9.

5. Bryukhova I.V. Shumskiy N.I., Masyanov Yu.N. Ostraya toksichnost primalaktata i ee vliyanie na biokhimicheskiy status korov [Acute toxicity of primalactat and its effect on the biochemical status of cows]. - International Bulletin of Veterinary Medicine. - 2015 (3). - pp. 62-66.

6. Bryukhova I.V. Effektivnost primeneniya primalakta dlya lecheniya endometrita u korov [Efficacy of the use of primalact for the treatment of endometritis in cows]. - Vitebsk, 2017.

7. Engalycheva G.N., Syubaev R.D., Goryachev D.V. Standarty kachestva doklinicheskikh farmakologicheskikh issledovaniy [Quality standards for preclinical pharmacological studies]. - DOI: 10.30895/1991-2919-2019-9-4-248-255.

8. Zhdanova I.N.Vliyaniye fitobakterialnogo kompleksa BCL na morfobiokhimicheskiy status korov s klinicheskoy formoy mastita [Effect of phytobacterial complex of BCL on the morphobiochemical status of cows with the clinical form of mastitis]. - DOI: 10.7242/1998-2097/2018.3.5.

9. Novikov V.V., Basova N.Yu., Makhfuz R.A., Skorikov A.V. Otsenka terapevticheskoy effektivnosti protivomastitnykh preparatov v usloviyakh molochno-tovarnykh ferm Krasnodarskogo kraya [Assessment of therapeutic efficacy of antimastitis preparations in conditions of dairy farms of Krasnodar region]. - DOI: 10.34617/2m3k-aa15.

10. Pimenov N.V. Izuchenie profilakticheskoy i lechebnoy effektivnosti preparata bakteriofag u korov s mastitom na molochnoy ferme [Study of the prophylactic and therapeutic efficacy of the bacteriophage drug in cows with mastitis on a dairy farm]. - DOI: 10.18551 / rjoas.2016-05.11.

11. Rukovodstvo po doklinicheskim issledovaniyam lekarstvennykh sredstv [Guidelines for preclinical studies of drugs]. - 2012. - 944 p.

12. Samuylenko A.Ya., Matveeva I.N., Evglevskiy D.A., Evglevskiy A.A., Grebennikova G.E. Biotekhnologicheskoe obosnovanie snizheniya toksichnosti i potentsirovaniya effektivnosti lechebno-profilakticheskikh preparatov [Biotechnological substantiation of toxicity reduction and potentiation of efficacy of therapeutic and prophylactic drugs]. - Bulletin of Kursk State Agricultural Academy. - Kursk, 2015 (6). - pp. 64-65.

13. Sorokina A.V., Alekseeva S.V., Eremina N.V., Durnev A.D. Opyt klinicheskikh i laboratornykh issledovaniy v doklinicheskoy otsenke bezopasnosti lekarstvennykh sredstv (Chast 1: gematologicheskiye issledovaniya) [Clinical and laboratory research experience in preclinical drug safety assessment (Part 1: hematological studies)]. -DOI: 10.30895 / 1991-2919-2019-9-3-197-206.

14. Tatarnikova N.A., Zhdanova I.N. Ispolzovanie ekdisteroidsoderzhashchik h preparatov v skheme lecheniya mastita u korov [Use of ecdysteroid-containing preparations in treatment regimen for mastitis in cows]. - News of OSAU (OGAU). -Orenburg, 2019 (6 (80). - pp. 208-211.

15-19. Vide supra.

Author affiliation:

Irina Viktorovna Bryukhova, Ph.D. in Veterinary Medicine, Senior Scientific Researcher of the Department of Experimental Pharmacology of the All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy; 114 b, Lomonosova st., Voronezh; phone: 8-903-6526316; e-mail: irina.bryuhova@mail.ru.

Vostroilova Galina A., D.Sc. in Biology, chief scientific researcher of the Department of Experimental Pharmacology of the All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy; 114 b, Lomonosova st., Voronezh; phone: 8-906-6781203; e-mail: gvostroilova@mail.ru.

Chaplygina Yuliya A., junior scientific researcher of the Department of Experimental Pharmacology of the All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy; 114 b, Lomonosova st., Voronezh; phone: 8-951-5553510; e-mail: kantorovich.yuliya@mail.ru.

Responsible for correspondence with the editorial board: Khokhlova Nina 1 A., scientific researcher of the Department of Experimental Pharmacology of the All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy; 114 b, Lomonosova st., Voronezh; phone: 8-908-1376923; e-mail: nina_xoxlova@mail.ru.


http://vetkuban.com/en/num5_202003.html